← Browse by Condition
Medical Condition

ret driver mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05800340 Phase 2
Recruiting

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Enrollment
30 pts
Location
China
Sponsor
Guangdong Provincial People's ...
View Trial →